LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Alcon Inc

Gesloten

SectorGezondheidszorg

76.57 -1.3

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

76.24

Max

77.58

Belangrijke statistieken

By Trading Economics

Inkomsten

-167M

183M

Verkoop

123M

2.6B

K/W

Sectorgemiddelde

34.44

105.69

Dividendrendement

0.45

Winstmarge

7.058

Werknemers

25,000

EBITDA

-213M

250M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.11% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.45%

2.37%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-7.1B

37B

Vorige openingsprijs

77.87

Vorige sluitingsprijs

76.57

Nieuwssentiment

By Acuity

72%

28%

341 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Alcon Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 nov 2025, 09:09 UTC

Winsten
Belangrijke Marktbewegers

Alcon Shares in Switzerland Climb After Guidance Confirmation

7 nov 2025, 15:42 UTC

Acquisities, Fusies, Overnames

Alcon, Staar Surgical Amend Merger Agreement to Allow Other Bids

2 sep 2025, 23:07 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

20 aug 2025, 17:21 UTC

Winsten
Belangrijke Marktbewegers

Alcon Shares Sink After Cut to Fiscal Year Sales Guidance

20 aug 2025, 08:46 UTC

Winsten
Belangrijke Marktbewegers

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

12 nov 2025, 08:46 UTC

Marktinformatie

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q Adj EPS 79c >ALC

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q Rev $2.61B >ALC.EB

11 nov 2025, 21:35 UTC

Winsten

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q EPS 48c >ALC.EB

11 nov 2025, 21:34 UTC

Winsten

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

11 nov 2025, 21:34 UTC

Winsten

Alcon Backs 2025 Net Sales $10.3B-$10.4B >ALC

11 nov 2025, 21:33 UTC

Winsten

Alcon 3Q EPS 48c >ALC

11 nov 2025, 21:33 UTC

Winsten

Alcon 3Q Rev $2.61B >ALC

7 nov 2025, 15:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Alcon Waives All Matching Rights for Third-Party Proposals, Info Rights During Go Shop Period >STAA

7 nov 2025, 15:10 UTC

Acquisities, Fusies, Overnames

Staar Surgical: No Termination Fee Payable to Alcon if STAAR Terminates Merger Agreement to Accept a Superior Proposal From a Qualified Bidder >STAA

7 nov 2025, 15:10 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Announces Amendments to Alcon Merger Agreement

27 okt 2025, 12:02 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions With Alcon

8 okt 2025, 15:44 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 okt 2025, 15:44 UTC

Acquisities, Fusies, Overnames

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 okt 2025, 15:43 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

6 okt 2025, 11:32 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Broadwood Presentation Recycles Flawed, Misleading, Misinformed Claims About Process and Considerations Leading Up to STAAR's Agreement With Alcon

26 sep 2025, 21:56 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22 sep 2025, 11:15 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16 sep 2025, 13:12 UTC

Acquisities, Fusies, Overnames

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16 sep 2025, 13:12 UTC

Acquisities, Fusies, Overnames

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16 sep 2025, 13:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16 sep 2025, 13:10 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

20 aug 2025, 17:06 UTC

Winsten
Belangrijke Marktbewegers

Alcon Shares Sink After Cut to FY Sales Guidance

19 aug 2025, 20:32 UTC

Winsten
Acquisities, Fusies, Overnames

Alcon Cuts 2025 View To Sales $10.3B-$10.4B >ALC.EB

Peer Vergelijking

Prijswijziging

Alcon Inc Prognose

Koersdoel

By TipRanks

24.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 96.37 USD  24.11%

Hoogste 119.571 USD

Laagste 77.53 USD

Gebaseerd op 19 Wall Street-analisten die 12-maands prijsdoelen bieden voor Alcon Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

19 ratings

14

Buy

5

Hold

0

Sell

Technische score

By Trading Central

95.77 / 97.61Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

341 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat